 |
|
|
|
Atopic dermatitis in tunisia. A multicentric retrospective study
|
|
|
Decreased sphingosine in the atopic stratum corneum may be associated with colonization by S. aureus
|
|
|
Analysis of skin prick testing to Pityrosporum ovale in atopic dermatitis using laser doppler perfusion imaging
|
|
|
IL-4 induced-eotaxin production in normal and atopic dermatitis fibroblasts
|
|
|
Adult onset atopic dermatitis
|
|
|
Multicentric study of the efficacy of a new emollient for atopic dermatitis. Effect on the quality of life
|
|
|
Growth velocity assessments of paediatric patients in long-term vehicle-controlled studies with pimecrolimus (SDZ ASM 981) cream 1%
|
|
|
Tacrolimus ointment (protopic) 0.03% twice daily as the therapy of choice in young paediatric patients (2-6 years) with moderate to severe AD
|
|
|
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines
|
|
|
A study looking at the role of food causing early and delayed aggravation of atopic dermatitis in chinese children
|
|
|
Immunomodulation induced by thermal spring water on TH1- and TH2-dependent cytokines production in healthy subjects and atopic dermatitis patients
|
|
|
IFN-gamma, SIL-2R, IL-4, IL-5 and IL-10 in sera of patients with atopic dermatitis in the course of specific immunotherapy
|
|
|
Sleep disturbances in atopic dermatitis
|
|
|
Cost-effectiveness analysis of tacrolimus ointment and topical corticosteroids in moderate to severe atopic dermatitis
|
|
|
Atopic dermatitis and fungi
|
|
|
An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema
|
|
|
Clobetasol propionate 0.5% is equivalent as lotion or emollient cream in atopic dermatitis
|
|
|
Staphylococcus aureus colonisation in adults with atopic dermatitis
|
|
|
Interest of a moisturizer milk containing oat rhealba extracts in atopic dermatitis
|
|
|
Allergological exploration of atopic dermatitis in children: Why, Who, How?
|
|
|
Pimecrolimus (SDZ ASM 981) cream 1% can be safely used in conjunction with topical corticosteroids: results of a long term paediatric study
|
|
|
A role for the atopy patch test in intrinsic atopic dermatitis
|
|
|
Pimecrolimus (SDZ ASM 981) cream: good tolerability in paediatric patients
|
|
|
Validation of the eczema area and severity index (EASI) for atopic dermatitis in 1,533 patients from the pimecrolimus 1% cream clinical programme
|
|
|
Time spent on treatment in atopic dermatitis, a new method of measuring morbidity in pediatric patients
|
|
|
Promoter polymorphisms of the IL-4R are associated with atopic dermatitis and psoriasis in Japan
|
|
|
Evaluation of allergen-specific ige antibodies by mast in atopic dermatitis of southern Taiwan
|
|
|
Role of food allergy in 86 atopic dermatitis patients from 1 to 3 years: a prospective study
|
|
|
Psychiatric adjustments and maternal attitudes in children with atopic dermatitis
|
|
|
Pimecrolimus (SDZ ASM 981) cream: a new treatment strategy for the long-term management of atopic dermatitis in infants
|
|
|
Lack of association of spink5 gene polymorphisms of atopic dermatitis in Japan
|
|
|
Increased levels of serum TIMP-1 but not MMP-3 in atopic dermatitis
|
|
|
Neuropeptides contents in the skin and serum of AD model mice (NC/NGA)
|
|
|
Fexofenadine is effective at reducing itching associated with atopic dermatitis
|
|
|
Quality of life (QOL) in patients with atopic dermatitis: impact of tacrolimus ointment
|
|
|
Epidermal dendritic cell phenotyping of atopy patch test lesions
|
|
|
Lichen amyloidosis associated with atopic dermatitis
|
|
|
IgE autoantibodies monitored in an atopic dermatitis patients under cyclosporin a treatment reflect tissue damage
|
|
|
Diet and japanese herbal medicine for recalcitrant atopic dermatitis: efficacy and safety of the treatment
|
|
|
Safety and efficacy of tacrolimus ointment monotherapy in over 7,900 atopic dermatitis patients: results of an open-label study
|
|
|
Long-term application of fluticasone propionate in children with atopic dermatitis
|
|
|
Tacrolimus ointment for the treatment of eyelid dermatitis
|
|
|
Pimecrolimus (SDZ ASM 981) cream 1%: minimal systemic absorption in infants with atopic dermatitis during long-term treatment
|
|
|
The clinical efficacy of multilamellar emulsion contained pseudoceramide (PC-9S) on atopic dermatitis
|
|
|
The comparison of proteome maps between sera of patients with atopic dermatitis and normal controls
|
|
|
The membrane fraction of Klebsiella pneumoniae (FMKP) decreases ige production
|
|
|
Efficacy of a thermal spring water in the treatment of mild atopic dermatitis
|
|
|
Immunophenotyping of inflammatory cells in atopic dermatitis skin lesions
|
|
|
Continuous vs intermittent cyclosporin therapy for severe atopic dermatitis
|
|
|
Pimecrolimus (SDZ ASM 981) cream is effective in patients aged 3 months to 17 years with atopic dermatitis
|
|
|
Familial form of the Buckley syndrome: two cases report
|
|
|
Keratitis, ichthyosis and deafness (KID) syndrome
|
|
|
Morphological and physiological analyses of the neck skin with reticulated pigmentation in atopic dermatitis
|
|
|
Skin specific caspase-1 transgenic mice as a new model for atopic dermatitis in a SPF condition: importance of IL-18
|
|
|
Epidemiology of atopic dermatitis in elementary schools of Tehran
|
|
|
Comparison of diagnostic criteria for the study of the epidemology of atopic dermatitis
|
|
|
Atopic dermatitis
|
|
|
Tacrolimus ointment is effective and safe in japanese atopic dermatitis children
|
|
|
Comparison of a generic and skin disease specific QOL instrument in AD
|
|
|
Epidemiologic study of atopic dermatitis in an area of Madrid
|
|
|
Role of climatic factors in atopic dermatitis: a multicentric clinico-epidemiological study
|
|
|
Atopic dermatitis is accompanied by increased sensitivity of airway afferent nerve-endings
|
|
|
Psychological personality structure in patients with atopic dermatitis
|
|
|
Mechanisms of extracorporeal photopheresis (EXP) in treatment of severe atopic dermatitis (AD)
|
|
|
Are melasma and atopy correlated?
|
|
|
Successful treatment of severe adult atopic dermatitis with low dose methotrexate
|
|
|
Severe atopic eczema in bangladeshi children in east London
|
|
|
Efficacy and safety comparison of desonide 0.05% lotion versus fluocortolone 0.5% ointment in atopic dermatitis
|
|
|
Tacrolimus ointment in the treatment of atopic dermatitis in children
|
|
|
Efficacy of 0.1% tacrolimus ointment in long-term treatment of atopic dermatitis
|
|
|
Tacrolimus ointment (protopic) shows superior efficacy and comparable safety in a short-term comparison versus corticosteroids in children with AD
|
|
|
Efficacy and safety of tacrolimus ointment (protopic) versus a mid-potent to potent corticosteroid in adults with moderate to severe atopic dermatitis
|
|
|
Paediatric patients with moderate to severe atopic dermatitis treated with tacrolimus ointment 0.03% show minimal systemic exposure
|
|
|
Effect of photoexcited titanium dioxide on the skin of DS-NH, model mouse of atopic dermatitis
|
|
|
10% urea: an effective moisturizer in various dry skin conditions
|
|
|
Atopic dermatitis and hypersensitivity to fungal antigens
|
|
|
Decrease of secretary IgA levels to Candida in patients with severe type of atopic dermatitis
|
|
|
Tender spots in patients with/without atopic dermatitis
|
|
|
The role of airborne allergens in the pathomechanism of atopic dermatitis
|
|
|
Specific immunotherapy in the treatment of selected patients with atopic dermatitis
|
|
|
In vitro effects of a spa water on the migratory and stimulatory capacities of human langerhans cells
|
|
|
The way from atopiform to atopic dermatitis
|
|
|
Atopic dermatitis and rantes promoter polymorphism
|
|
|
Variations of enzyme markers versus clinical regression of atopic dermatitis
|
|
|
Relative importance of IL-13 and IL-4 in lesional skin of atopic dermatitis
|
|
|
Payer costs of atopic dermatitis & eczema in children in the United States
|
|
|
Plasma levels of nerve growth factor and substance P in atopic dermatitis
|
|
|
Imunofan in treatment of atopic dermatitis
|
|
|
Tacrolimus pharmacokinetics (PK) in paediatric patients with moderate to severe atopic dermatitis (AD) after single and repeated application
|
|
|
Pharmacokinetic (PK) of tacrolimus ointment in adult patients with moderate to severe atopic dermatitis
|
|
|
Mavena MG46 dead sea salt balneotherapy accelerates restoration of barrier function in japanese skin
|
|
|
Food allergy and atopic dermatitis: current thoughts & recommendations
|
|
|
The utility of patch testing in atopic dermatitis
|
|
|
Alternative treatments for atopic dermatitis: a selected review
|
|
|
The cost effectiveness of pimecrolimus (SDZ ASM 981) topical cream 1% and corticosteroids in the treatment of atopic dermatitis
|
|
|
Impact of practice of sport on atopic dermatitis
|
|
|
Pimecrolimus (SDZ ASM 981) cream reduces the number of flares and is steroid sparing: a 1-year, double-blind, controlled study in children
|
|
|
The effect of staphylococcal toxins on atopic dermatitis
|
|
|
Pimecrolimus (SDZ ASM 981) in the treatment of atopic eczema: benefit to quality of life among infants
|
|
|
Pimecrolimus (SDZ ASM 981) in the treatment of paediatric atopic eczema: benefit to quality of life and health-related quality of life
|
|
|
Presence of toxins produced by Staphylococcus aureus in sera of patients with atopic dermatitis
|
|
|
Serum cytokine levels in atopic dermatitis
|
|
|
The study on atopic dermatitis by Pi Yan Xiao Jing Ying II
|
|
|
The pathogenetic substantiation of the treatment of atopic dermatitis in children of the early age with eubiotics
|
|
|
Associations of childhood atopic dermatitis
|
|
|
The prevalence of systemic infections in atopic dermatitis patients
|
